Financials • Specialty Insurers
$43.62 ▲ +0.79
(+1.85%)
MKT CAP: $2.83B • VOL: 798.4K
52W L $9 52W H $45
ROARABLE / RQD
C- • 61/100
PIOTROSKI
6 / 9
LIFE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 |
|---|---|---|
| Revenue (Total Sales) | $387.6M | $254.9M |
| YoY Revenue Growth % | +52.0% | — |
| Gross Profit | — | — |
| Gross Margin % | — | — |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | $72.9M | $48.7M |
| Operating Margin % | 18.8% | 19.1% |
| Net Income (GAAP) | $71.2M | $48.8M |
| EBITDA (Normalized) | $74.1M | $49.4M |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | $36.2M | -$10.9M |
| Capital Expenditures (CapEx) | $1.5M | $776.0K |
| Free Cash Flow (FCF) | $34.7M | -$11.7M |
| FCF Margin % | 9.0% | -4.6% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% |
| Cash & Short-Term Equivalents | $91.1M | $35.1M |
| Total Debt (Short + Long Term) | — | — |
| Total Stockholders' Equity | -$24.1M | -$107.2M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LIFE.